Received Feb 12, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEPA | HEP A (VAQTA) | MERCK & CO. INC. | 2 | Unknown | — |
| HEPA | HEP A (VAQTA) | MERCK & CO. INC. | 1 | — | — |
No effects reported; received the first dose at 12 months and the second dose at 15 months; This solicited report was received from a nurse and refers to 15-month-old patient of unknown gender. The patient's medical history, past medications, concomitant medications and current conditions were not reported. On approximately November 2025 (reported as 12-months-old), the patient was vaccinated with the first dose of hepatitis a vaccine, inactivated (VAQTA) (strength, route of administration, anatomical site of application, lot number and expiration date were not provided) and the second dose of hepatitis a vaccine, inactivated (VAQTA) (PFS) on 10-Feb-2026 (also reported as at 15-months-old) lot number Azo10429 with expiration date reported as 09-Oct-2026 that has been verified to be invalid (strength, route of administration, anatomical site of application were not provided) both of them at a dose of 0.5 ml administered for prophylaxis (Inappropriate schedule of product administration). No effects reported (No adverse event).